$XTLB News
Last published 4mo ago
- 4mo agoXTLBXTL Completed the Acquisition of Psyga Bio Ltd.GlobeNewswireexpands its IP portfolio to clinical-stage biopharmaceutical assets XTL Biopharmaceuticals (XTL) Completes the Acquisition of Psyga Bio and Establishes Psychedelic Biotechnology Platform At a historic juncture and
- 5mo agoXTLBXTL Announces Receipt of Staff Delist Determination from NasdaqGlobeNewswireRAMAT GAN, ISRAEL, May 22, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced today that it has received a letter (the "Letter") from The Listing
- 6mo agoXTLBXTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin TechnologiesGlobeNewswireTransaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory Momentum Seven Approved Phase 2a Human Clinical Trials Expected to Begin Patient
- 8mo agoXTLBXTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request HearingGlobeNewswireRAMAT GAN, ISRAEL, Feb. 27, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced today that it has received a letter (the "Letter") from The Listing
- 9mo agoXTLBXTL Update on Recent DevelopmentsGlobeNewswireRAMAT GAN, ISRAEL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced that it is working diligently to close the acquisition of 85% of the
- 9mo agoXTLBXTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity DeficiencyGlobeNewswireRAMAT GAN, ISRAEL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced today that it has received a notification letter from The Listing
- 10mo agoXAIRXTLBXTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific LeadershipGlobeNewswireUnmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying
- 10mo agoXAIRXTLBXTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific LeadershipGlobeNewswireUnmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying
- 10mo agoXTLBXTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price DeficiencyGlobeNewswireRAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced today that it has received a notification letter from The Listing
- 1y agoXTLBXTL Names Mr. Noam Band as its New Chief Executive OfficerGlobeNewswireBrings a Wealth of Managerial Experience and Track Record RAMAT GAN, ISRAEL, April 07, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL") announced today the
- 2y agoXTLBXTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 MillionGlobeNewswireexpands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Completed a Private Placement of $1.5 Million
- 2y agoXTLBXTL Entered Definitive Agreement to Acquire The Social ProxyGlobeNewswireexpands its IP portfolio to AI Web Data The Social Proxy is a web data AI company developing and powering an IP based platform for AI & BI Applications at scale Secured $1.5 Million in a Private
- 2y agoXTLBXTL To Aquire The Social ProxyGlobeNewswireexpands its IP portfolio to AI Web Data The Social Proxy is a web data AI companydeveloping and powering an IP based platform for AI & BI Applications at scale Secured $1.5 Million in a Private Placement
- 3y agoXTLBXTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyGlobeNewswireRamat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB, TASE: XTLB.TA)) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets
- 3y agoXTLBXTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in IsraelGlobeNewswireRamat Gan, Israel, Oct. 20, 2023 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB, TASE: XTLB.TA)) ("XTL" or the "Company"), a clinical stage biopharmaceutical company whose main assets
- 5y agoSCPSXTLBDr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual MeetingPR NewswireJERUSALEM, Sept. 20, 2021 /PRNewswire/ -- Dr. Morris C. Laster today announced that he has filed preliminary proxy materials with the Securities and Exchange Commission ("SEC") in connection with the 2021 Annual Meeting of Stockholders ("Annual Meeting"
- 6y agoXAIRAPOPXTLBSeedo Corp. Appoints New Board of DirectorsGlobeNewswireYoqneam, Israel, July 01, 2020 (GLOBE NEWSWIRE) -- Seedo Corp. (OTC: SEDO) (“Seedo”) announced its shareholders have elected a new Board of Directors. The new Board brings decades of executive...